Management of suspected lyme borreliosis: Experience from an outpatient parenteral antibiotic therapy service

QJM: An International Journal of Medicine

Volumn 106, Issue 2, 2013, Pages 133-138

  White, B ^a   Seaton, R A ^a   Evans, T J ^a,b  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE;

ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; ANAPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; CATHETER INFECTION; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; DYSPEPSIA; FATIGUE; FEMALE; HEADACHE; HERPES ZOSTER; HUMAN; LIVER DYSFUNCTION; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; OUTCOME ASSESSMENT; OUTPATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; THRUSH; TREATMENT RESPONSE; UVEITIS;

EID: 84873260266     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcs189     Document Type: Article

References (14)

1. British Infection Association. The epidemiology, prevention, investigation and treatment of Lyme borreliosis in United Kingdom patients: a position statement by the British Infection Association. J Inf 2011; 62:329-38.
2. Duncan CJA, Carle G, Seaton RA. Tick bite and early Lyme borreliosis. BMJ 2012; 344:e3124.
3. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines of the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010; 17:8-16.
4. Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345:85-92.
5. Pikelj F, Strle F, Mozina M. Seronegative Lyme disease and transitory atrioventricular block. Ann Intern Med 1989; 111:90.
6. Dejmkova H, Hulinska D, Tegzova D, Pavelka K, Gatterova J, Vavrik P. Seronegative Lyme arthritis caused by Borrelia garinii. Clin Rheumatol 2002; 21:330-4.
7. Cottle LE, Mekonnen E, Beadsworth MBJ, Miller ARO, Beeching NJ. Lyme disease in a British referral clinic. Q J Med 2012; 105:537-43.
8. Slack CS, Mavin S, Yirrel D, Ho-Yen DO. Is Tayside becoming a Scottish hotspot for Lyme borreliosis? J R Coll Physicians Edinb 2011; 41:5-8.
9. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme diseases, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the infections diseases society of America. Clin Inf Dis 2006; 43:1089-134.
10. Seaton RA, Sharp E, Bezlyak V, Weir CJ. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and softtissue infections. Int J Antimicrob Agents 2011; 38:243-8.
11. Wormser GP, Nadelman RB, Dattwyler RJ, Dennis DT, Shapiro ED, Steere AC, et al. Practice Guidelines for the Treatment of Lyme Disease. Clin Inf Dis 2000; 31(Suppl. 1):S1-S14.
12. Barbour AG. Expert advice and patient expectations: laboratory testing and antibiotics for Lyme disease. JAMA 1998; 279:239-40.
13. Chapman ALN, Seaton RA, Cooper MA, Hedderwick S, Goodall V, Reed C, et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother 2012; 67:1053-62.
14. Drug information online. http://www.drugs.com/sfx/ceftriaxone-side-effects.html (30 June 2012, date last accessed).